This week in BIOEMTECH, we were happy and honoured to be participating at the International Atomic Energy Agency (IAEA) Technical Meeting on “The Preclinical Testing of Radiopharmaceuticals”, taking place in in Portugal. Interesting and fruitful discussions on the different preclinical approaches to ascertain the risks for translation of radiotracers for first in human use are on-going and we are excited to be part of them and share our experience, rationale and workflows. Looking forward to the final meeting’s remarks and their implementation, in making preclinical testing of radiopharmaceuticals more efficient, faster and safer – the ultimate goal for all of us, in preclinical research!
10 January 2022